Erythromycin Ethylsuccinate
Erythromycin Ethylsuccinate for Oral Suspension, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate for oral suspension and other antibacterial drugs, erythromycin ethylsuccinate for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
46f74c4f-10fc-44cf-aec4-d113f49149bc
HUMAN PRESCRIPTION DRUG LABEL
Jan 2, 2024
Nivagen Pharmaceuticals, Inc.
DUNS: 052032418
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Erythromycin Ethylsuccinate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (6)
Erythromycin Ethylsuccinate
Product Details
FDA regulatory identification and product classification information